Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Novacyt
Novacyt
Activities:
Analysis
X
LinkedIn
Trending Articles
IMPACT CKD model reveals the escalating toll of chronic kidney disease
The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Isospec Analytics launches biomolecular analysis technology to identify unknown molecules
The novel technology optimises the identification process of unknown molecules compared to mass analysis
Building strong foundations for a resilient and planet-friendly future
Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector
The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Novacyt launches assays for SARS-CoV-2 variants
Novacyt’s existing polymerase chain reaction (PCR) COVID-19 portfolio remains highly accurate in detecting all published SARS-CoV-2 variants, the company says
Finance
Novacyt signs contract to supply PCR instruments to UK DHSC
This is the second major contract awarded by the DHSC to Primerdesign, Novacyt’s molecular diagnostics division, during the COVID-19 pandemic
Regulatory
French institute approves Novacyt COVID-19 test
The CNR approval has meant the CE-Mark test is available in markets which directly accept CE-Mark accreditation without the need for further approval
Finance
Novacyt reports increased sales and new deals for outbreak diagnostics
France-based Novacyt has provided an update on its business moves that have resulted from the novel COVID-19
Infection Control
Novacyt launches novel coronavirus test
The Primerdesign coronavirus test has the ability to detect only the 2019 strain of the virus
Finance
Novacyt completes substantial q16 molecular diagnostics order
Expands clinical diagnostic reach in fast growing Chinese market
Subscribe now